BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21157138)

  • 41. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epstein-Barr virus (EBV) infections in patients treated with allogenic hematopoietic cells transplantation (allo-HCT)].
    Zawilińska B; Piatkowska-Jakubas B; Kopeć J; Daszkiewicz E; Kleszcz E; Szostek S; Mensah-Glanowska P; Hawrylecka D; Skotnicki A
    Przegl Epidemiol; 2006; 60(1):87-92. PubMed ID: 16758744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation.
    Carpenter B; Haque T; Dimopoulou M; Atkinson C; Roughton M; Grace S; Denovan S; Fielding A; Kottaridis PD; Griffiths P; Mackinnon S; Emery V; Chakraverty R
    Transplantation; 2010 Sep; 90(5):564-70. PubMed ID: 20555307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence, kinetics, and risk factors of Epstein-Barr virus viremia in pediatric patients after allogeneic stem cell transplantation.
    Bordon V; Padalko E; Benoit Y; Dhooge C; Laureys G
    Pediatr Transplant; 2012 Mar; 16(2):144-50. PubMed ID: 22288846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
    Ahmad I; Cau NV; Kwan J; Maaroufi Y; Meuleman N; Aoun M; Lewalle P; Martiat P; Crokaert F; Bron D
    Transplantation; 2009 Apr; 87(8):1240-5. PubMed ID: 19384173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.
    Fafi-Kremer S; Brengel-Pesce K; Barguès G; Bourgeat MJ; Genoulaz O; Seigneurin JM; Morand P
    J Clin Virol; 2004 Jun; 30(2):157-64. PubMed ID: 15125872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
    Gotoh K; Ito Y; Shibata-Watanabe Y; Kawada J; Takahashi Y; Yagasaki H; Kojima S; Nishiyama Y; Kimura H
    Clin Infect Dis; 2008 May; 46(10):1525-34. PubMed ID: 18419486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring of EBV-DNAemia by quantitative real-time PCR after adult liver transplantation.
    Loginov R; Aalto S; Piiparinen H; Halme L; Arola J; Hedman K; Höckerstedt K; Lautenschlager I
    J Clin Virol; 2006 Oct; 37(2):104-8. PubMed ID: 16931140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children.
    Faraci M; Caviglia I; Morreale G; Lanino E; Cuzzubbo D; Giardino S; Di Marco E; Cirillo C; Scuderi F; Dallorso S; Terranova P; Moroni C; Castagnola E
    Bone Marrow Transplant; 2010 Jun; 45(6):1052-5. PubMed ID: 19855442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
    Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
    Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?
    Meijer E; Spijkers S; Moschatsis S; Boland GJ; Thijsen SF; van Loon AM; Verdonck LF
    Transpl Infect Dis; 2005 Mar; 7(1):4-10. PubMed ID: 15984942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C; Aurora P; Burch M; Cubitt D; Lloyd C; Whitmore P; Neligan SL; Elliott MJ
    J Heart Lung Transplant; 2005 Dec; 24(12):2103-8. PubMed ID: 16364857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
    Jabs WJ; Hennig H; Kittel M; Pethig K; Smets F; Bucsky P; Kirchner H; Wagner HJ
    J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.
    Fafi-Kremer S; Morand P; Barranger C; Barguès G; Magro S; Bés J; Bourgeois P; Joannes M; Seigneurin JM
    J Mol Diagn; 2008 Jan; 10(1):78-84. PubMed ID: 18165270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y; Ito Y; Kaneko K; Shibata-Watanabe Y; Tainaka T; Sumida W; Nakamura T; Kamei H; Kiuchi T; Ando H; Kimura H
    Transplant Proc; 2008 Dec; 40(10):3578-82. PubMed ID: 19100443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real-time polymerase chain reaction.
    Wagner HJ; Fischer L; Jabs WJ; Holbe M; Pethig K; Bucsky P
    Transplantation; 2002 Sep; 74(5):656-64. PubMed ID: 12352882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation.
    Liu Q; Xuan L; Liu H; Huang F; Zhou H; Fan Z; Zhao K; Wu M; Xu L; Zhai X; Zhang F; Liu C; Sun J; Huang X
    Am J Hematol; 2013 Jul; 88(7):550-5. PubMed ID: 23564232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K; Hassan J; Staines A; Coughlan S; Holder P; Tuite G; McCormick AP; Traynor O; Hall WW; Connell J
    Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation.
    Jeulin H; Salmon A; Gautheret-Dejean A; Agut H; Bordigoni P; Fortier B; Venard V
    J Clin Virol; 2009 May; 45(1):43-6. PubMed ID: 19321385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.